MiNK Therapeutics, Inc.
INKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $26,094 | $36,765 | $87,886 | $149,305 |
| - Cash | $4,577 | $3,367 | $19,636 | $38,889 |
| + Debt | $4,925 | $0 | $0 | $0 |
| Enterprise Value | $26,442 | $33,398 | $68,251 | $110,416 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$215 | -$205 | -$122 | -$78 |
| % Margin | – | – | – | – |
| EBITDA | -$10,569 | -$22,253 | -$27,869 | -$27,703 |
| % Margin | – | – | – | – |
| Net Income | -$10,785 | -$22,458 | -$27,991 | -$30,213 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.8 | -6.54 | -8.31 | -9.03 |
| % Growth | 57.2% | 21.3% | 8% | – |
| Operating Cash Flow | -$9,555 | -$15,763 | -$18,867 | -$12,827 |
| Capital Expenditures | -$0 | -$74 | -$250 | -$249 |
| Free Cash Flow | -$9,555 | -$15,836 | -$19,117 | -$13,076 |